Pages that link to "Q41697538"

The following pages link to Growth factor-mediated angiogenesis in the malignant progression of glial tumors: A review (Q41697538):

Displaying 47 items.

• AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma (Q28365043) (← links)
• Combining cytotoxic and immune-mediated gene therapy to treat brain tumors (Q31013320) (← links)
• Magnetic resonance image–guided proteomics of human glioblastoma multiforme (Q31018100) (← links)
• Efficient production of human acidic fibroblast growth factor in pea (Pisum sativum L.) plants by agroinfection of germinated seeds (Q33891467) (← links)
• Antiangiogenic therapy in brain tumor models (Q33938969) (← links)
• Roles of transforming growth factor-alpha and related molecules in the nervous system. (Q34019161) (← links)
• Genes that regulate metastasis and angiogenesis (Q34178906) (← links)
• Gliomagenesis: genetic alterations and mouse models (Q34186001) (← links)
• Molecular biology of nervous system tumors (Q34480160) (← links)
• Antiangiogenesis in neurofibromatosis 1. (Q34982037) (← links)
• Anti-angiogenic agents for the treatment of brain tumors (Q35104246) (← links)
• Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma (Q35113661) (← links)
• Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells (Q35748364) (← links)
• Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo (Q35788931) (← links)
• Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report (Q35799962) (← links)
• Analysis of dynamic contrast enhanced MRI. (Q36022692) (← links)
• Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling (Q36065454) (← links)
• Immunotherapy for malignant glioma: current approaches and future directions (Q36273693) (← links)
• Current immunotherapeutic strategies for central nervous system tumors (Q36325239) (← links)
• Dendritic cell-based active specific immunotherapy for malignant glioma (Q36764903) (← links)
• The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas (Q36833480) (← links)
• Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy. (Q37849781) (← links)
• Transforming growth factor-beta and its implication in the malignancy of gliomas (Q38192972) (← links)
• A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses (Q38297197) (← links)
• Reduced glioma infiltration in Src-deficient mice (Q39010683) (← links)
• Granulocyte–macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas (Q39422092) (← links)
• Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain (Q39774256) (← links)
• Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells (Q39953614) (← links)
• Steroids and adrenomedullin growth patterns in human ovarian cancer cells: estrogenic-regulation assay (Q40607437) (← links)
• Thalidomide as an anti-angiogenic agent in relapsed gliomas (Q40708350) (← links)
• FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities (Q40855352) (← links)
• VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab. (Q41714150) (← links)
• Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression (Q41966417) (← links)
• Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. (Q43805704) (← links)
• Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. (Q44421351) (← links)
• Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma (Q47577124) (← links)
• Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans (Q47992994) (← links)
• Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma (Q48342333) (← links)
• A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme (Q48399854) (← links)
• TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors (Q48434089) (← links)
• Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood. (Q52566324) (← links)
• Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. (Q53654471) (← links)
• Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. (Q55467287) (← links)
• Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. (Q55473889) (← links)
• Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. (Q55475521) (← links)
• Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma (Q61443163) (← links)
• Glioblastoma multiforme (Q81521004) (← links)